Capital Fund Management (CFM)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62M Sell
67,400
-73,700
-52% -$74.7M 0.28% 48
2025
Q4
$152M Buy
141,100
+6,800
+5% +$6.5M 0.42% 20
2025
Q3
$102M Sell
134,300
-900
-0.7% -$670K 0.27% 55
2025
Q2
$105M Buy
135,200
+53,000
+64% +$41.2M 0.29% 50
2025
Q1
$67.9M Sell
82,200
-60,100
-42% -$50M 0.2% 141
2024
Q4
$110M Buy
142,300
+20,800
+17% +$17.2M 0.28% 68
2024
Q3
$108M Sell
121,500
-36,900
-23% -$33.2M 0.29% 77
2024
Q2
$143M Sell
158,400
-36,100
-19% -$28.9M 0.42% 33
2024
Q1
$151M Buy
194,500
+22,000
+13% +$15.7M 0.44% 20
2023
Q4
$101M Buy
172,500
+73,900
+75% +$43.1M 0.27% 73
2023
Q3
$53M Buy
98,600
+16,400
+20% +$8.45M 0.18% 143
2023
Q2
$38.6M Sell
82,200
-12,700
-13% -$5.33M 0.16% 168
2023
Q1
$32.6M Buy
94,900
+62,700
+195% +$21.1M 0.16% 168
2022
Q4
$11.8M Sell
32,200
-62,100
-66% -$22M 0.08% 348
2022
Q3
$30.5M Buy
94,300
+69,300
+277% +$22M 0.24% 102
2022
Q2
$8.11M Sell
25,000
-60,800
-71% -$18.3M 0.07% 371
2022
Q1
$24.6M Sell
85,800
-74,800
-47% -$19.3M 0.2% 124
2021
Q4
$44.4M Buy
160,600
+27,900
+21% +$7.07M 0.32% 50
2021
Q3
$30.7M Buy
132,700
+42,000
+46% +$10.4M 0.23% 107
2021
Q2
$20.8M Buy
90,700
+47,700
+111% +$9.58M 0.16% 149
2021
Q1
$8.03M Buy
43,000
+22,200
+107% +$4.34M 0.09% 279
2020
Q4
$3.51M Sell
20,800
-11,800
-36% -$1.76M 0.03% 593
2020
Q3
$4.83M Sell
32,600
-31,700
-49% -$4.91M 0.06% 359
2020
Q2
$10.6M Sell
64,300
-129,100
-67% -$19.8M 0.17% 178
2020
Q1
$26.8M Sell
193,400
-83,500
-30% -$11.5M 0.42% 42
2019
Q4
$36.4M Buy
276,900
+6,200
+2% +$719K 0.29% 83
2019
Q3
$30.3M Sell
270,700
-12,700
-4% -$1.41M 0.27% 94
2019
Q2
$31.4M Sell
283,400
-64,900
-19% -$7.64M 0.29% 79
2019
Q1
$45.2M Buy
348,300
+42,300
+14% +$5.14M 0.4% 39
2018
Q4
$35.4M Buy
306,000
+112,500
+58% +$12.6M 0.31% 62
2018
Q3
$20.8M Buy
193,500
+189,400
+4,620% +$18.9M 0.11% 263
2018
Q2
$350K Sell
4,100
-4,100
-50% -$337K ﹤0.01% 1738
2018
Q1
$634K Sell
8,200
-25,900
-76% -$2.09M ﹤0.01% 1377
2017
Q4
$2.88M Buy
34,100
+8,200
+32% +$698K 0.02% 853
2017
Q3
$2.21M Sell
25,900
-1,200
-4% -$98.4K 0.02% 742
2017
Q2
$2.23M Sell
27,100
-45,100
-62% -$3.68M 0.02% 682
2017
Q1
$6.07M Sell
72,200
-57,900
-45% -$4.64M 0.05% 404
2016
Q4
$9.57M Buy
+130,100
New +$9.69M 0.08% 309
2016
Q3
Sell
-36,000
Closed -$2.83M 1693
2016
Q2
$2.83M Sell
36,000
-12,300
-25% -$926K 0.03% 619
2016
Q1
$3.48M Sell
48,300
-19,500
-29% -$1.48M 0.03% 543
2015
Q4
$5.71M Sell
67,800
-35,300
-34% -$2.93M 0.06% 410
2015
Q3
$8.63M Buy
103,100
+54,200
+111% +$4.58M 0.1% 268
2015
Q2
$4.08M Buy
48,900
+18,300
+60% +$1.39M 0.05% 425
2015
Q1
$2.22M Sell
30,600
-208,600
-87% -$14.9M 0.03% 558
2014
Q4
$16.5M Sell
239,200
-134,900
-36% -$9.11M 0.2% 130
2014
Q3
$24.3M Buy
374,100
+9,300
+3% +$589K 0.27% 83
2014
Q2
$22.7M Buy
364,800
+115,400
+46% +$6.89M 0.24% 103
2014
Q1
$14.7M Buy
249,400
+189,600
+317% +$10.6M 0.18% 122
2013
Q4
$3.05M Buy
59,800
+27,800
+87% +$1.39M 0.04% 554
2013
Q3
$1.61M Buy
32,000
+3,200
+11% +$168K 0.02% 718
2013
Q2
$1.42M Buy
+28,800
New +$1.57M 0.02% 713

Other funds holding LLY

Capital Fund Management (CFM)'s LLY Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Eli Lilly (LLY) in Q1 2026: 189,558 shares worth $174M. The stake represents 0.79% of the portfolio and ranks #8 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in LLY as recently as Q3 2025.

Capital Fund Management (CFM) first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capital Fund Management (CFM) held 189,558 shares of Eli Lilly worth $174M as of Q1 2026.
  • Eli Lilly was a new Capital Fund Management (CFM) position in Q1 2026.
  • Eli Lilly made up 0.79% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #8 holding.
  • Capital Fund Management (CFM) first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.